New device could keep donor livers healthier before transplant
NCT ID NCT06916325
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a device that keeps donor livers cool and oxygenated before transplant, aiming to reduce early liver problems. About 215 first-time liver transplant patients will receive a liver preserved with this method. The goal is to see if it lowers the risk of early graft dysfunction and improves overall survival.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- dual hypothermic oxygenated perfusion (DHOPE) using the Liver Assist device
- What this could lead to
- If successful, this could make more donor livers available for transplant and reduce early liver damage after surgery.
- What could go wrong
- This is an early-stage study without a control group, so results may not prove the device is better than standard preservation. Risks include potential device-related complications or no improvement in outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for END STAGE LIVER DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a simple scan and blood test outsmart liver cancer?
- Could a vaccine help fight Hard-to-Treat cancers?
- Could a tailored diet before surgery boost liver cancer recovery?
- Can a new PET tracer light up hidden cancers?
- Can immune cells predict herpesvirus danger in transplant patients?
- A new test could reveal how radiation affects the liver